Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · IEX Real-Time Price · USD
1.110
+0.020 (1.83%)
At close: Mar 28, 2024, 4:00 PM
1.120
+0.010 (0.90%)
After-hours: Mar 28, 2024, 7:56 PM EDT

Bionano Genomics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019201820172016
Cash & Equivalents
18.355.4924.5738.4517.3116.521.025.25
Short-Term Investments
83.94108.1226.0400000
Cash & Cash Equivalents
102.29113.59250.6138.4517.3116.521.025.25
Cash Growth
-9.95%-54.68%551.80%122.10%4.77%1516.87%-80.53%-
Receivables
9.327.024.932.786.334.513.351.85
Inventory
22.8929.7612.393.323.441.071.691.8
Other Current Assets
5.626.934.482.251.170.921.071.84
Total Current Assets
140.12157.3272.4146.7928.2623.037.1410.74
Property, Plant & Equipment
32.4828.9620.944.911.951.783.014.05
Goodwill and Intangibles
33.97118.43838.650000
Other Long-Term Assets
7.832.810.750.10000
Total Long-Term Assets
74.29150.2104.6913.661.951.783.014.05
Total Assets
214.4307.5377.160.4530.2124.810.1514.79
Accounts Payable
10.3812.5310.772.932.71.352.30.79
Deferred Revenue
0.9410.830.510.540.580.350.69
Current Debt
72.242.551.77020.0806.730.59
Other Current Liabilities
16.4719.818.485.53.042.67.267.29
Total Current Liabilities
100.0335.8821.848.9526.374.5216.659.36
Long-Term Debt
7.189.128.9316.3309.0306.05
Other Long-Term Liabilities
11.0413.19.210.10.231.110.711.22
Total Long-Term Liabilities
18.2222.2218.1416.420.2310.140.717.27
Total Liabilities
118.2558.139.9825.3726.5914.6717.3616.63
Total Debt
79.4111.6710.716.3320.089.036.736.63
Debt Growth
580.61%9.09%-34.48%-18.72%122.44%34.17%1.46%-
Retained Earnings
-581.21-348.72-216.12-143.68-102.58-72.76-54.27-30.9
Comprehensive Income
0.02-1.12-0.5400000
Shareholders' Equity
96.16249.4337.1235.083.6110.14-50.23-27.26
Net Cash / Debt
22.88101.92239.9222.12-2.777.49-5.71-1.38
Net Cash / Debt Growth
-77.56%-57.52%984.42%-----
Net Cash Per Share
0.673.528.672.12-1.8510.59-21.13-6.05
Working Capital
40.09121.41250.5737.841.8918.5-9.511.37
Book Value Per Share
2.828.6212.183.372.4114.32-185.95-119.25
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).